Drug interactions
Insulin aspart + Selegiline transdermal
Severity: Moderate
Insulin aspart and Selegiline transdermal: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
MAO inhibitors have been reported to enhance the hypoglycemic effect of insulin and other antidiabetic agents. Transdermal selegiline at antidepressant doses may do the same, though data are limited.
What this interaction means in plain words
Insulin aspart and Selegiline transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
MAO inhibition may increase insulin sensitivity and alter gluconeogenesis; the exact mechanism is not established.
What to do
Monitor blood glucose when selegiline is started or stopped. Reduce the insulin aspart dose if hypoglycemia occurs.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin aspart and Selegiline transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Insulin aspart
Frequently asked questions
Can I take Insulin aspart with Selegiline transdermal?
MediHelp rates the interaction as moderate. Insulin aspart and Selegiline transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. MAO inhibitors have been reported to enhance the hypoglycemic effect of insulin and other antidiabetic agents. Transdermal selegiline at antidepressant doses may do the same, though data are limited.
How serious is the interaction between Insulin aspart and Selegiline transdermal?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when selegiline is started or stopped. Reduce the insulin aspart dose if hypoglycemia occurs.
What other medicines interact with Insulin aspart?
MediHelp also lists interactions of Insulin aspart with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin aspart page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
